Overview
Hirofumi Yamakawa practices practicing medicine in Nanakuma, Japan.
Their clinical expertise encompasses Acute Promyelocytic Leukemia.
They are actively involved in clinical research, co-authoring 9 peer reviewed articles.
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Frequently Asked Questions about Hirofumi Yamakawa
Is Hirofumi Yamakawa a top-rated expert for Acute Promyelocytic Leukemia?
MediFind is an objective health platform that identifies experts based on real-world data. Hirofumi Yamakawa is classified as an Experienced expert for Acute Promyelocytic Leukemia, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
Does Hirofumi Yamakawa participate in research or clinical trials?
Yes. Hirofumi Yamakawa has published 9 articles and abstracts on conditions like Acute Promyelocytic Leukemia. You can view a list of Hirofumi Yamakawa's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Experienced
- Acute Promyelocytic LeukemiaYamakawa isExperienced. Learn about Acute Promyelocytic Leukemia.